Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 59 (HNRNPA1P59)

Target
HNRNPA1P59
Molecular classification
Pseudogene, Processed pseudogene
01

Overview

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 59 (HNRNPA1P59) is a human processed pseudogene related by sequence to the HNRNPA1 gene, which encodes a major RNA-binding protein involved in RNA processing. HNRNPA1P59 does not encode a functional protein due to accumulated mutations, and there are no known physiological roles or disease associations assigned to this pseudogene. Like other pseudogenes, it could theoretically have regulatory activity at the RNA level (e.g., as a competing endogenous RNA), but no functional data are available for this specific pseudogene. It should not be considered a conventional drug target or therapeutic receptor. HNRNPA1P59 is not a protein, receptor, or enzyme; it is not a therapeutic target or disease biomarker; and there is no evidence supporting its utility in drug discovery or clinical settings.

02

Biological functions

There is no established protein-coding function for this pseudogene.Some pseudogenes can have regulatory roles at the RNA level (as competitive endogenous RNAs or sources of noncoding RNAs) in specific cellular contexts, but there is no direct evidence for this for HNRNPA1P59 specifically.
03

Disease associations

Some pseudogenes have been implicated in cancer and other diseases; however, there is no published evidence directly linking HNRNPA1P59 to disease mechanisms.
04

Safety considerations

None identified, as this gene is not a therapeutic target and does not produce a protein product.

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 59 (HNRNPA1P59).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 59 (HNRNPA1P59).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call